197 related articles for article (PubMed ID: 17360144)
21. The role of sentinel lymph node biopsy in the management of melanoma.
Amersi F; Morton DL
Adv Surg; 2007; 41():241-56. PubMed ID: 17972569
[TBL] [Abstract][Full Text] [Related]
22. Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review.
Sutthatarn P; Davidoff AM; Bahrami A; Richard C; Shalini B; Santiago TC; Shulkin BL; Pappo AS; Abdelhafeez A
Pediatr Surg Int; 2024 Mar; 40(1):68. PubMed ID: 38441654
[TBL] [Abstract][Full Text] [Related]
23. Thick primary melanoma has a heterogeneous tumor biology: an institutional series.
Meguerditchian AN; Asubonteng K; Young C; Lema B; Wilding G; Kane JM
World J Surg Oncol; 2011 Apr; 9():40. PubMed ID: 21492474
[TBL] [Abstract][Full Text] [Related]
24. Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
Deckers EA; Kruijff S; Bastiaannet E; van Ginkel RJ; Hoekstra-Weebers JEHM; Hoekstra HJ
J Surg Oncol; 2021 Sep; 124(4):655-664. PubMed ID: 34085291
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: Can we predict involvement?
Parker LM; Beekman KE; DePalo DK; Elleson KM; Zager JS
J Surg Oncol; 2024 May; ():. PubMed ID: 38720442
[TBL] [Abstract][Full Text] [Related]
26. Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.
Tarhini AA; Zahoor H; Yearley JH; Gibson C; Rahman Z; Dubner R; Rao UN; Sander C; Kirkwood JM
J Transl Med; 2015 Sep; 13():319. PubMed ID: 26419843
[TBL] [Abstract][Full Text] [Related]
27. Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial.
Favre G; Guani B; Balaya V; Magaud L; Lecuru F; Mathevet P
Front Oncol; 2020; 10():621518. PubMed ID: 33680944
[TBL] [Abstract][Full Text] [Related]
28. Update and Review on the Surgical Management of Primary Cutaneous Melanoma.
Leilabadi SN; Chen A; Tsai S; Soundararajan V; Silberman H; Wong AK
Healthcare (Basel); 2014 Jun; 2(2):234-49. PubMed ID: 27429273
[TBL] [Abstract][Full Text] [Related]
29. Head & neck melanoma: A 22-year experience of recurrence following sentinel lymph node biopsy.
Echanique KA; Ghazizadeh S; Moon A; Kwan K; Pellionisz PA; Rünger D; Elashoff D; St John M
Laryngoscope Investig Otolaryngol; 2021 Aug; 6(4):738-746. PubMed ID: 34401498
[TBL] [Abstract][Full Text] [Related]
30. Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous Melanoma.
Jackson KM; Jones PC; Fluke LM; Fischer TD; Thompson JF; Cochran AJ; Stern SL; Faries MB; Hoon DSB; Foshag LJ
JAMA Netw Open; 2024 Feb; 7(2):e2354751. PubMed ID: 38319662
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia.
Huynh J; Leiter U; Garbe C; Shiderova G; Walter V; Eigentler T; Scheu A; Häfner HM; Schnabl SM
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):84-92. PubMed ID: 37611257
[TBL] [Abstract][Full Text] [Related]
32. Between Pathological Prostate Cancer Lymph Nodes and Sentinel Nodes: Which Information Is the Leader?
Morel A; Rousseau T; Ferrer L; Lacoste J; Nevoux P; Picot-Dilly E; Le Thiec M; Rusu D; Campion L; Rousseau C
Clin Nucl Med; 2024 May; ():. PubMed ID: 38776066
[TBL] [Abstract][Full Text] [Related]
33. Melanoma m (zero): diagnosis and therapy.
Rastrelli M; Alaibac M; Stramare R; Chiarion Sileni V; Montesco MC; Vecchiato A; Campana LG; Rossi CR
ISRN Dermatol; 2013; 2013():616170. PubMed ID: 23691346
[TBL] [Abstract][Full Text] [Related]
34. Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients.
Maione V; Perantoni M; Bettolini L; Bighetti S; Arisi M; Tomasi C; Incardona P; Calzavara-Pinton P
Melanoma Res; 2024 May; ():. PubMed ID: 38564432
[TBL] [Abstract][Full Text] [Related]
35. Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S; Duarte-Bateman D; Fowler G; Hagstrom MNE; Lampley N; Olivares S; Fumero-Velázquez MS; Vu K; Wayne JD; Gastman BR; Vetto J; Gerami P
Arch Dermatol Res; 2023 Oct; 315(8):2295-2302. PubMed ID: 36977840
[TBL] [Abstract][Full Text] [Related]
36. Depth of invasion analysis to predict acral melanoma outcomes.
Asato MA; Moares-Neto FA; de Toledo Moraes MP; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
Ann Diagn Pathol; 2024 Apr; 71():152305. PubMed ID: 38640808
[TBL] [Abstract][Full Text] [Related]
37. Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina.
Ishida H; Nagai T; Sato S; Honda M; Uotani T; Samejima K; Hanaoka T; Akahori T; Takai Y; Seki H
Springerplus; 2015; 4():102. PubMed ID: 25763309
[TBL] [Abstract][Full Text] [Related]
38. Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins.
Weitman ES; Perez MC; Lee D; Kim Y; Fulp W; Sondak VK; Sarnaik AA; Gonzalez RJ; Cruse CW; Messina JL; Zager JS
Melanoma Manag; 2019 Jun; 6(2):MMT17. PubMed ID: 31406562
[TBL] [Abstract][Full Text] [Related]
39. Online prediction tools for melanoma survival: A comparison.
Dixon A; Steinman HK; Kyrgidis A; Smith H; Sladden M; Zouboulis C; Argenziano G; Apalla Z; Lallas A; Longo C; Nirenberg A; Popescu C; Tzellos T; Cleaver L; Zachary C; Anderson S; Thomas JM
J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):1999-2003. PubMed ID: 37210649
[TBL] [Abstract][Full Text] [Related]
40. SENTINEL LYMPH NODE- A POSSIBLE GUARANTEE OF RECURRENCE-FREE SURVIVAL.
Tchernev G
Georgian Med News; 2023 Jun; (339):143-146. PubMed ID: 37522790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
